We are focused on selling a wide range of specialist products, primarily in the immunoassay, in-vitro diagnostics (IVD) market within three segments: Autoimmune, Food Intolerance & Wellbeing and Infectious Disease.
Since listing in 2006, we have combined an organic and acquisitive growth strategy to establish a significant presence in its chosen product and geographic areas.
A focus on specific, specialised product categories together with a core competency of export sales has allowed us to establish a strong sales track record.
Originally founded as Omega Diagnostics Ltd in Scotland, our global reputation stems from beginnings as a manufacturer of tests for a range of infectious diseases such as syphilis, tuberculosis, dengue fever, chagas disease and malaria. Our export success was officially recognised with the Queen’s Award for Export Achievement in 1993, providing a solid foundation for future success.
Our product range was extended following the acquisition of Genesis Diagnostics Ltd and Cambridge Nutritional Sciences Ltd in September 2007 giving our customers access to tests for the fast growing area of food intolerance testing, as well those for autoimmune diseases.
In 2010, we acquired the IVD division of allergy and specific immunotherapy specialist Allergopharma Joachim Ganzer KG, giving further access to a range of allergy tests for over 600 allergens. This gave us a position in allergy testing that could be exploited in two ways. First, by driving international sales of current products through its existing global distribution network; and second by delivering a panel of automated allergy tests in conjunction with Immunodiagnostics Systems’ IDS-iSYS platform.